Related Experiment Videos

[Observation of platelet activation in coronary heart disease]

F G Li1, G X Wu, P X Li

  • 1Thrombosis and Hemostasis Research Unit, Suzhou Medical College.

Zhonghua Nei Ke Za Zhi
|January 1, 1993
PubMed

Insights

Platelet activation, measured by granule membrane protein-140 (GMP-140), peaks 48 hours post-acute myocardial infarction (AMI) and is lower in unstable angina (UA) patients compared to AMI. GMP-140 levels normalize within days to weeks.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Immunology

Context:

  • Platelet activation is a key factor in acute myocardial infarction (AMI) and unstable angina (UA).
  • Granule membrane protein-140 (GMP-140) is a marker of platelet activation.
  • Assessing platelet activation can aid in understanding cardiovascular disease progression.

Purpose:

  • To evaluate platelet activation in patients with AMI and UA using a monoclonal antibody against GMP-140.
  • To determine the temporal changes in platelet surface GMP-140 and plasma GMP-140 concentrations following AMI.
  • To compare the degree of platelet activation between AMI and UA patients.

Summary:

  • A monoclonal antibody targeting GMP-140 was used to assess platelet activation in 16 AMI and 14 UA patients.
  • GMP-140 on platelet surfaces peaked at 48 hours post-AMI, returning to baseline by day seven.
  • Plasma GMP-140 increased by day one, normalizing by day ten, with lower activation observed in UA compared to AMI.

Impact:

  • Provides insights into the kinetics of platelet activation in AMI and UA.
  • Highlights GMP-140 as a potential biomarker for assessing platelet activation in cardiovascular events.
  • Suggests differential platelet activation patterns between AMI and UA, relevant for clinical management.

Related Concept Videos